Careers & Tenders
Subscribe

Ingram Critical Care

No image available
Article
/ 2 June 2008

Tribunal confirms Adcock fine

The Competition Tribunal on Monday confirmed the consent order agreement between the Competition Commission and respondents Adcock Ingram Critical Care, Dismed Criticare, Thusanong Healthcare and Tiger Brands. Last month Adcock Ingram admitted liability for colluding on prices and agreed to pay an administrative penalty of R53,5-million.

By
No image available
Article
/ 9 May 2008

Tiger Brands to ‘clean house’

Tiger Brands is starting a company-wide review to ensure there is no more anti-competitive behaviour after cartels in the healthcare and bread and milling sectors were recently exposed, CEO Peter Matlare said on Friday. ”We are cleaning house. We are going door-to-door and cupboard-to-cupboard,” Matlare told reporters in Johannesburg.

By
No image available
Article
/ 9 May 2008

Adcock Ingram admits role in medicines cartel

Adcock Ingram Critical Care, a healthcare unit of JSE-listed Tiger Brands, has been fined R53,5-million, or 8% of its annual turnover, for admitting its role in fixing the prices of medicines supplied to hospitals, the local anti-trust authorities said on Friday. The matter was referred to the Competition Tribunal on February 11 2008.

By
No image available
Article
/ 12 February 2008

Adcock head suspended in collusion probe

The head of Adcock Ingram Critical Care, Tiger Brands’s healthcare division, has been suspended following allegations of collusion by the Competition Commission, the company said on Tuesday. Tiger Brands non-executive chairperson Lex van Vught said the company is ”devastated” by the allegations.

By
No image available
Article
/ 11 February 2008

Pharmaceutical companies accused of collusion

The Competition Commission has referred three pharmaceutical companies to the Competition Tribunal for prosecution after they were found to be colluding when bidding for government tenders, it said on Monday. ”Collusive behaviour would undoubtedly be one of the contributing factors to higher prices in healthcare,” said competition commissioner Shan Ramburuth.

By